Clinical Trial Update: Lumason® Infusion vs. Bolus Administrations [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing infusion versus bolus administration of Lumason ultrasound contrast. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• LUMASON (sulfur hexafluoride lipid microspheres)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Heart Diseases | Phase 3 | Status: RECRUITING